This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Emerging incretin- and multi-agonist-based treatments - the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio-kidney-liver-metabolic diseases and beyond.
Metabolism: clinical and experimental, 177, 156494
Citation
Muzurović, Emir; Katsiki, Niki; Volčanšek, Špela; Plescia, Fulvio; Rizzo, Manfredi; Mantzoros, Christos S. (2026). Emerging incretin- and multi-agonist-based treatments - the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio-kidney-liver-metabolic diseases and beyond.. Metabolism: clinical and experimental, 177, 156494. https://doi.org/10.1016/j.metabol.2026.156494